Preclinical Bioanalysis

Once discovery bioanalysis work is complete, our scientists can seamlessly carry your compound through preclinical PK and toxicology, all within the Bioanalytical Services Unit. Building on the knowledge gained during previous stages, we are able to significantly reduce timelines for our clients by eliminating the need to transfer a compound from one unit to another. Our preclinical bioanalytical services support toxicology activities for small and large molecule drugs with global regulatory compliance.

LC-MS/MS Platform

The Bioanalytical Services unit provides preclinical safety assessments to the highest international quality standards using LC-MS/MS, with on-site method development, qualification/validation and sample analysis.

+ Over 100k samples analyzed per year
+ 120 global IND/NDA packages filed
+ 70+ GLP QA and animal welfare audits passed

Immunochemistry Platform

Our immunochemistry platform measures large molecule products, including biologics, biomarkers and vaccines using state-of-the-art equipment and advanced automation systems. Operating out of 20,000 square feet of GLP lab space, the Bioanalytical Services unit has the capacity to handle over 40,000 samples per month at peak time and has validated 75 biomarker assays to date.

Over 60 Large Molecule Products Supported
+ 30+ Antibodies
+ 10+ Recombinant Proteins
+ 10+ Peptides
+ 10+ Fusion Proteins
+ 4 Antibody Drug Conjugates

Over 200 Assays Validated
+ 50+ PK
+ 30+ ADA
+ 10+ Nab
+ 130+ Biomarker

Abgent | A WuXi AppTec Company

View Abgent’s catalogue of antibody solutions, including reagent development and custom protein expression.